Skip to main content
NKMAX Co., Ltd. logo

NKMAX Co., Ltd. — Investor Relations & Filings

Ticker · 182400 ISIN · KR7182400002 KO Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2019-04-26 Director's Dealing
Country KR South Korea
Listing KO 182400

About NKMAX Co., Ltd.

https://nkmax.com/

NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 98% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea to report changes in shareholdings by major shareholders or insiders. Based on the provided filing categories, this document represents a notification of changes in significant share ownership levels, which aligns with the 'Major Shareholding Notification' (MRQ) category.
2019-04-26 Korean
투자설명서
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a '투자설명서' (Investment Prospectus) issued by '주식회사 에이티젠' (ATGen Co., Ltd.) regarding a merger. It contains detailed information about the merger, business risks, financial risks, and investment considerations. In the context of financial filings, a prospectus for a merger or securities offering is classified as a Proxy Solicitation & Information Statement (PSI) because it provides shareholders with the necessary information to make an informed voting decision regarding the corporate action.
2019-04-26 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of Extraordinary General Meeting' (임시주주총회 소집공고) issued by Atgen Co., Ltd. It contains the meeting agenda, voting procedures, and detailed management information including board activities, remuneration, and business outlook (Management's Discussion and Analysis). This document is a standard proxy statement/information circular provided to shareholders to solicit votes and inform them of meeting details, which falls under the 'Proxy Solicitation & Information Statement' category.
2019-04-26 Korean
의결권대리행사권유참고서류
M&A Activity Classification · 100% confidence The document is a 'Securities Registration Statement' (증권신고서) filed by ATGen Co., Ltd. with the Financial Services Commission. It details a merger between ATGen and NKMAX, including the purpose of the merger, the merger ratio, the schedule, and the issuance of new shares. This document is a formal regulatory filing required for corporate mergers and acquisitions under the Capital Markets Act. It is not a simple announcement (RPA) but the full registration statement itself, which falls under the 'M&A Activity' category.
2019-04-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (under the Capital Markets Act) used to disclose significant changes in share ownership by major shareholders and their special related parties. This document specifically details the shareholding status, changes in holdings, and collateral agreements of the major shareholder (Park Sang-woo) of the company 'ATGen'. This falls under the category of Major Shareholding Notification.
2019-04-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details changes in share ownership by a major shareholder (Korea Investment Value Asset Management) in the company 'Atigen'. This type of filing is specifically used to report significant changes in shareholding levels by major shareholders or insiders, which corresponds to the 'Major Shareholding Notification' category.
2019-04-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.